Versant Venture Management, LLC
San Francisco, CA · CIK 1560009 · 13F filing filed 2026-08-12
Exempt reporting adviser since 2012 · limited liability company
- Private funds28 · $3.9bn gross assets
- Websiteversantventures.com
- Form ADV · 2026-03-30SEC adviser record
- Kindventure
- Others nearbySan Francisco, CA, Basel, San Diego, CA, New York, NY, Toronto, Minneapolis, MN
As an employer
- Offices in3 countries
- Private fundsventure capital 28
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| San Francisco, CA (main office)United States | |
| BaselSwitzerland | 5 |
| San Diego, CAUnited States | 4 |
| New York, NYUnited States | 3 |
| TorontoCanada | 2 |
| Vancouver, BcCanada | 1 |
| Edina, MNUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$162.6m
reported value
+15.0% vs Q1 2026
8positions
100.0%in top 10
0 new
0 added
1 reduced
0 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MONTE ROSA THERAPEUTICS INC GLUE | $77.0m47.34% | Unchanged |
| CENTURY THERAPEUTICS INC IPSC | $29.8m18.33% | Unchanged |
| JADE BIOSCIENCES INC JBIO | $22.0m13.55% | Reduced -534.0k |
| LENZ THERAPEUTICS INC LENZ | $15.1m9.28% | Unchanged |
| CONTINEUM THERAPEUTICS INC CTNM | $8.9m5.47% | Unchanged |
| CRISPR THERAPEUTICS AG CRSP | $8.1m4.99% | Unchanged |
| SKYE BIOSCIENCE INC COM NEW | $1.4m0.86% | Unchanged |
| TEMPEST THERAPEUTICS INC COM | $299.4k0.18% | Unchanged |